Dupixent gets EU nod for children with severe atopic dermatitis
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive…
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive…
CytoReason, which creates computational disease modeling, has announced an expansion of its collaboration with Sanofi.…
The New England Journal of Medicine has published results from a positive phase 3 trial…
Sanofi and Innate Pharma SA have expanded their collaboration, with Sanofi licensing a natural killer (NK)…
The European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European…
Neuraxpharm Group, a European pharmaceutical company focused on the treatment of central nervous system (CNS)…
BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices,…
TrialSpark has announced the formation of Libertas Bio following the acquisition of a majority position…
Sanofi’s treatment, Enjaymo, for hemolytic anemia in adult patients with cold agglutinin disease (CAD), has…
AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has been approved in the European Union (EU) for the…
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a…
Sanofi and GSK’s Covid booster vaccine has been approved in Europe. After the European Medicines…